Showing 141-150 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes Regents of the University of Colorado Jessica Kendrick Improving Lives 01-October-2022 to 30-September-2025 $899,235.00
Islet autoantibody concordance and metabolic monitoring of individuals identified at risk for type 1 diabetes through population-based screening Regents of the University of Colorado Kimber Simmons Cures 01-July-2023 to 30-June-2026 $750,000.00
Innovating Methods for AssessinG INsulin Action in Type ONe diabetes (IMAGINATiON) Regents of the University of Colorado Kristen Nadeau Improving Lives 01-December-2021 to 30-November-2025 $445,816.29
Validation of Enzyme-linked immunosorbent assay (ELISA) to detect insulin autoantibodies Regents of the University of Colorado Liping Yu Cures 01-June-2025 to 31-May-2027 $453,852.00
Antigenic Targets of CD4 T cells across the stages of type 1 diabetes Regents of the University of Colorado Maki Nakayama Cures 01-August-2022 to 31-July-2026 $750,000.00
Autoimmunity Screening for Kids (ASK) Regents of the University of Colorado Marian Rewers Cures 01-November-2024 to 31-October-2027 $3,074,807.75
IL-37-EXPRESSING TREG CELLS TO IMPROVE T1D THERAPEUTIC STRATEGY Regents of the University of Colorado Mayumi Fujita Cures 01-March-2023 to 28-February-2026 $750,000.00
Clinical and Economic Optimization Platform for Type 1 Diabetes Screening Regents of the University of Colorado R. Brett McQueen Cures 01-September-2022 to 31-August-2024 $483,523.62
Improving the Uptake and Applicability of the Clinical and Economic Optimization Platform for Type 1 Diabetes Screening Regents of the University of Colorado R. Brett McQueen Cures 01-September-2024 to 31-August-2026 $451,890.07
Defining human T cell-myeloid cell interactions in the islets Regents of the University of Colorado Rachel Friedman Cures 01-March-2023 to 28-February-2026 $110,000.00